Neuromuscular Involvement in Glycogen Storage Disease Type III in Fifty Tunisian Patients: Phenotype and Natural History in Young Patients

Neuropediatrics. 2019 Feb;50(1):22-30. doi: 10.1055/s-0038-1669786. Epub 2018 Oct 11.

Abstract

Background: Our aim was to describe the natural history of neuromuscular involvement (NMI) in glycogen storage disease type III (GSDIII).

Methods: We conducted a longitudinal study of 50 Tunisian patients, 9.87 years old in average.

Results: NMI was diagnosed at an average age of 2.66 years and was clinically overt in 85% of patients. Patients with clinical features were older (p = 0.001). Complaints were dominated by exercise intolerance (80%), noticed at 5.33 years in average. Physical signs, observed at 6.75 years in average, were dominated by muscle weakness (62%). Functional impairment was observed in 64% of patients, without any link with age (p = 0.255). Among 33 patients, 7 improved. Creatine kinase (CK) and aspartate aminotransferase (AST) levels were higher with age.Electrophysiological abnormalities, diagnosed in average at 6.5 years, were more frequent after the first decade (p = 0.0005). Myogenic pattern was predominant (42%). Nerve conduction velocities were slow in two patients. Lower caloric intake was associated with more frequent clinical and electrophysiological features. Higher protein intake was related to fewer complaints and physical anomalies.

Conclusion: Neuromuscular investigation is warranted even in asymptomatic patients, as early as the diagnosis of GSDIII is suspected. Muscle involvement can be disabling even in children. Favorable evolution is possible in case of optimal diet.

MeSH terms

  • Child
  • Child, Preschool
  • Cross-Sectional Studies
  • Female
  • Follow-Up Studies
  • Glycogen Storage Disease Type III / blood
  • Glycogen Storage Disease Type III / diagnosis*
  • Glycogen Storage Disease Type III / epidemiology*
  • Humans
  • Infant
  • Longitudinal Studies
  • Male
  • Muscle, Skeletal / metabolism
  • Muscle, Skeletal / pathology
  • Neuromuscular Diseases / blood
  • Neuromuscular Diseases / diagnosis*
  • Neuromuscular Diseases / epidemiology*
  • Phenotype*
  • Retrospective Studies
  • Tunisia / epidemiology